The Effect of Dextrose Hypotonic Vs Saline Hydration on Methotrexate-Induced Nephrotoxicity in Male and Female Rats

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2024 Mar 25

PMID 38525397

Authors

Zahra Hasanpour

Samira Choopani

Farzaneh Ashrafi

Ardeshir Talebi

Mehdi Nematbaksh

Affiliations

Soon will be listed here.

Abstract

Background: High-dose methotrexate (HDMTX) as a cytotoxic agent might cause various side effects. Hyperhydration has been implemented as the major strategy to decrease the potential risk of toxicities induced by HDMTX. This study aims to assess the renoprotective effect of hydration with dextrose water (DW) 5% versus normal saline (N/S) 0.9% against methotrexate (MTX) induced nephrotoxicity.

Materials And Methods: This experimental animal study has been conducted on 36 Wistar rats (200-250 g) categorized into six groups, including male ( = 6) and female ( = 6) rats receiving sodium chloride 0.9% saline plus MTX, DW 5% plus MTX, or MTX alone. By the fifth day after the MTX injection, biochemical indexes were measured. The rats were also sacrificed and renal specimens were evaluated microscopically to determine kidney tissue damage (KTD).

Results: The groups were not significantly different with regard to blood urea nitrogen (BUN) ( = 0.5), creatinine (Cr) ( = 0.24), kidney weight ( = 0.34), and urine flow (UF) ( = 0.5), while KTD score was remarkably less in the hydrated groups ( < 0.001). Weight loss in DW-treated rats was significantly more than N/S-treated ones, and creatinine clearance (CrCl) and urine load (UL) of Cr were statistically similar between males and females in the control group, but significantly lower among the DW5% treated males.

Conclusion: Based on the findings of this study, hydration with N/S was superior to DW5% for the prevention from HDMTX-induced nephrotoxicity. Besides, we found insignificant differences between male versus female rats in response to the hydration for HDMTX-induced renoprotection; however, females probably benefit more.

References

Medrano C, Oberic L, Puisset F, Recher C, Larrieu-Ciron D, Ysebaert L . Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients. Leuk Lymphoma. 2020; 62(4):846-853. DOI: 10.1080/10428194.2020.1846733. View

Svahn T, Mellgren K, Harila-Saari A, Asberg A, Kanerva J, Jonsson O . Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2016; 64(7). DOI: 10.1002/pbc.26395. View

Perazella M, Rosner M . Drug-Induced Acute Kidney Injury. Clin J Am Soc Nephrol. 2022; 17(8):1220-1233. PMC: 9435983. DOI: 10.2215/CJN.11290821. View

Francois M, Takagi K, Legrand R, Lucas N, Beutheu S, Bole-Feysot C . Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia. Front Nutr. 2016; 3:23. PMC: 4960292. DOI: 10.3389/fnut.2016.00023. View

Mashayekhi-Sardoo H, Mohammadpour A, Nomani H, Sahebkar A . The effect of diabetes mellitus on pharmacokinetics, pharmacodynamics and adverse drug reactions of anticancer drugs. J Cell Physiol. 2019; 234(11):19339-19351. DOI: 10.1002/jcp.28644. View

Wiczer T, Dotson E, Tuten A, Phillips G, Maddocks K . Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity. J Oncol Pharm Pract. 2015; 22(3):430-6. DOI: 10.1177/1078155215594417. View

Traivaree C, Likasitthananon N, Monsereenusorn C, Rujkijyanont P . The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients. Cancer Manag Res. 2018; 10:4471-4478. PMC: 6188117. DOI: 10.2147/CMAR.S172117. View

Abdel-Raheem I, Khedr N . Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats. Naunyn Schmiedebergs Arch Pharmacol. 2013; 387(4):341-53. DOI: 10.1007/s00210-013-0949-x. View

Karstila K, Korpela M, Sihvonen S, Mustonen J . Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol. 2007; 26(12):2089-2095. DOI: 10.1007/s10067-007-0625-y. View

10.

Amin A, Effat D, Goher N, Ramadan B . Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?. Rheumatol Int. 2012; 33(12):3059-63. DOI: 10.1007/s00296-012-2620-0. View

11.

Myers C, Hoelzinger D, Truong T, Chew L, Myles A, Chaudhuri L . Chemotherapy can induce weight normalization of morbidly obese mice despite undiminished ingestion of high fat diet. Oncotarget. 2017; 8(3):5426-5438. PMC: 5354920. DOI: 10.18632/oncotarget.14576. View

12.

Boukhettala N, Leblond J, Claeyssens S, Faure M, Le Pessot F, Bole-Feysot C . Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am J Physiol Endocrinol Metab. 2008; 296(1):E182-90. DOI: 10.1152/ajpendo.90459.2008. View

13.

Mikkelsen T, Mamoudou A, Tuckuviene R, Wehner P, Schroeder H . Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study. Pediatr Blood Cancer. 2013; 61(2):297-301. DOI: 10.1002/pbc.24623. View

14.

Amitai I, Rozovski U, El-Saleh R, Shimony S, Shepshelovich D, Rozen-Zvi B . Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies. Hematol Oncol. 2020; 38(4):584-588. DOI: 10.1002/hon.2759. View

15.

Mangum R, Bernhardt M, Cheng W, Schafer E, Berg S, Foster J . Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage. Pediatr Blood Cancer. 2020; 67(9):e28334. DOI: 10.1002/pbc.28334. View

16.

Karremann M, Sauerbier J, Meier C, Vetter C, Schneider H, Buchholz B . The impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients. Leuk Lymphoma. 2014; 55(12):2874-8. DOI: 10.3109/10428194.2014.898143. View

17.

Kinoshita A, Kurosawa Y, Kondoh K, Suzuki T, Manabe A, Inukai T . Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2003; 51(3):256-60. DOI: 10.1007/s00280-002-0565-9. View

18.

Khan Z, Tripathi R, Mishra B . Methotrexate: a detailed review on drug delivery and clinical aspects. Expert Opin Drug Deliv. 2012; 9(2):151-69. DOI: 10.1517/17425247.2012.642362. View

19.

Aldemir M, Okulu E, Kosemehmetoglu K, Ener K, Topal F, Evirgen O . Evaluation of the protective effect of quercetin against cisplatin-induced renal and testis tissue damage and sperm parameters in rats. Andrologia. 2013; 46(10):1089-97. DOI: 10.1111/and.12197. View

20.

Howard S, McCormick J, Pui C, Buddington R, Harvey R . Preventing and Managing Toxicities of High-Dose Methotrexate. Oncologist. 2016; 21(12):1471-1482. PMC: 5153332. DOI: 10.1634/theoncologist.2015-0164. View